News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|December 20, 2022

Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

Author(s)Jeffrey L Alvaro, MD

Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.

Episodes in this series

EP. 1 Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

EP. 1 Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Later ADHD diagnosis linked to worse educational outcomes | Image Credit: © NDABCREATIVITY - © NDABCREATIVITY - stock.adobe.com.

Later ADHD diagnosis linked to worse educational outcomes

ByCeleste Krewson, Assistant Editor

April 8th 2026

Rebecca Chasnovitz, MD, highlights updates in pediatric ADHD medication | Image Credit: unchealth.org.

Rebecca Chasnovitz, MD, highlights updates in pediatric ADHD medication

ByRebecca Chasnovitz, MD

February 24th 2026

Aldo Conti, PhD, says trigeminal nerve stimulation ineffective for pediatric ADHD | Image Credit: kcl.ac.uk.

Aldo Conti, PhD, says trigeminal nerve stimulation ineffective for pediatric ADHD

ByAldo A. Conti, BSc, MSc, PhD, CPsychol

February 9th 2026

Brain stimulation device found ineffective for managing pediatric ADHD | Image Credit: © ClareM - © ClareM - stock.adobe.com.

Brain stimulation device found ineffective for managing pediatric ADHD

ByCeleste Krewson, Assistant Editor

February 3rd 2026

Low Apgar score, cord pH linked to ADHD risk | Image Credit: © BazziBa - © BazziBa - stock.adobe.com.

Low Apgar score, cord pH linked to ADHD risk

ByCeleste Krewson, Assistant Editor

January 30th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA grants priority review to Tivicay PD for neonatal HIV

Recent advances in the treatment of molluscum contagiosum

RSV Monoclonal Antibody Resistance: What Clinicians Need to Know

Weekly review: Formula recall, FDA warning for bassinet, and more

RSV Maternal Immunization vs. Monoclonal Antibodies: Comparing Immunity and Practical Differences